Nutex Health Inc.: Pertento Partners LLP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Pertento Partners LLP amended its Schedule 13G filing on Nutex Health Inc., updating its disclosed stake in the healthcare company with the SEC under accession number 0000919574-26-007680. The amendment revises the investment firm's previously reported ownership position, though the filing did not specify a change in share count or percentage in the headline disclosure. Schedule 13G filings are required of investors holding passive stakes above 5% in a public company, making the update a signal of Pertento's current position in Nutex. Investors will watch for the full filing details to see whether Pertento increased, trimmed or maintained its holding, and whether the change reflects broader institutional interest in the micro-cap hospital operator.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Pertento Partners LLP, Nutex Health Inc.